FFP
PLSE icon

FourThought Financial Partners’s Pulse Biosciences PLSE Stock Holding History

FourThought Financial Partners’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,724
Closed -$188K – 501
2025
Q4 		$188K Sell
13,724
-6,328
-32% -$98.6K 0.02% 470
2025
Q3 		$355K Buy
+20,052
New +$317K 0.03% 253

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

FourThought Financial Partners's PLSE Position: Q1 2026 in Review

FourThought Financial Partners sold out of Pulse Biosciences (PLSE) in Q1 2026, closing a stake of 13,724 shares — an estimated $188K sold.

FourThought Financial Partners first reported a position in PLSE in Q3 2025 and held it in 2 quarters. The position peaked at $355K in Q3 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • FourThought Financial Partners reported no remaining Pulse Biosciences position as of Q1 2026 after selling out during the quarter.
  • FourThought Financial Partners sold 13,724 Pulse Biosciences shares in Q1 2026, an estimated $188K.
  • FourThought Financial Partners first reported a position in Pulse Biosciences in Q3 2025 and held it in 2 quarters.
  • FourThought Financial Partners's Pulse Biosciences position peaked at $355K in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.